Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,610 | -29,658 | -18,931 | -10,604 | -42,942 |
| Depreciation Amortization | 1,217 | 904 | 584 | 285 | 709 |
| Accounts payable and accrued liabilities | -5,298 | -5,682 | -3,730 | -982 | 5,764 |
| Other Working Capital | -5,752 | -3,513 | -4,141 | -1,249 | -199 |
| Other Operating Activity | 12,413 | 11,153 | 7,423 | 2,612 | 3,033 |
| Operating Cash Flow | $-35,030 | $-26,796 | $-18,796 | $-9,938 | $-33,636 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29 | -29 | -29 | N/A | N/A |
| Investing Cash Flow | $-29 | $-29 | $-29 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,181 | -41 | -27 | -14 | -59 |
| Common Stock Issued | 23,369 | 20,057 | 20,026 | 20,026 | 16,436 |
| Financing Cash Flow | $20,188 | $20,016 | $19,998 | $20,012 | $16,377 |
| Beginning Cash Position | 56,561 | 56,561 | 56,561 | 56,561 | 73,820 |
| End Cash Position | 41,690 | 49,751 | 57,734 | 66,634 | 56,561 |
| Net Cash Flow | $-14,871 | $-6,809 | $1,173 | $10,074 | $-17,260 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,030 | -26,796 | -18,796 | -9,938 | -33,636 |
| Capital Expenditure | -29 | -29 | -29 | N/A | N/A |
| Free Cash Flow | -35,059 | -26,825 | -18,825 | -9,938 | -33,636 |